SAN ANTONIO--(BUSINESS WIRE)--Modulim, recognized leader in optical imaging solutions for non-invasive assessment of tissue health, will exhibit its groundbreaking Clarifi™ Imaging System publicly for the first time this week at the Symposium on Advanced Wound Care (SAWC) Spring Meeting in San Antonio, Texas.
Powered by Modulim’s proprietary optical imaging technique – spatial frequency domain imaging (SFDI) – Clarifi offers clinicians a fast, reliable, and objective method of assessing tissue oxygenation and perfusion in patients with potential circulatory compromise. The technology helps clinicians characterize subsurface tissue beneath the skin to evaluate compromised circulation, which has been known to contribute to conditions such as critical limb ischemia, non-healing wounds and foot complications.
The SAWC Spring | Wound Healing Society event (running May 7-11, 2019) features new cutting-edge topics led by influential educators and thought leaders in wound healing to further move the wound care community forward, and create a dynamic and unified voice to support the shared mission of improving patient care.
“It is exciting to be unveiling our Clarifi system at SAWC this year,” said David Cuccia, Ph.D., Modulim’s founding CEO and CTO. “As we ramp up our national launch and commercialization process for Clarifi, it’s remarkable to be able to provide a hands-on opportunity for clinicians to see how it works. Attendees will gain a sense of how this vital new tool can impact their practice and patient care.”
“Our mission is prevention,” added Cuccia. “To that end, our technology is designed to provide clinicians with clinically actionable information to identify patients with compromised circulation, and pinpoint the potential areas of concern, so that targeted care can be implemented.”
Live, hands-on demos of Clarifi will be available at Modulim’s booth (#120) on the exhibit floor throughout the SAWC event.
Modulim is a pioneer in subsurface optical imaging powered by SFDI, an advanced imaging technique co-invented by founding CEO and CTO David Cuccia, Ph.D. SFDI is a non-invasive tissue oxygen saturation technology that combines structured illumination with multiple wavelengths of light (visible and near-infrared) to allow for deeper and layer-specific assessment of tissue oxygenation and hemoglobin. This unique technology deciphers the reflection, absorbance, and scattering of light in tissue to accurately measure key biomarkers of tissue health and quantifies two key perfusion metrics not identified by any other technology: HbT1 and HbT2. Modulim’s new Clarifi™ Imaging System, powered by SFDI, is indicated for measuring tissue oxygenation and perfusion in patients with potential circulatory compromise. With its’ widespread adoption, this approach could save thousands of limbs and lives, as well as billions of dollars in treatment costs. For more information, visit modulim.com.